Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trizivir and Tenofovir in HIV Early Virologic Failure
NCT00038506Phase 4Completed
- Sponsor
- ViiV Healthcare
- Start
- Mar 2002
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of abacavir and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by ViiV Healthcare. Primary endpoint: Proportion of subjects with undetectable viral load at 48 weeks. Started Mar 2002; status: completed.
02
Drugs
abacavirtenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00038506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038506.